Cart
sales@molnova.com
RUSKI-201
CAS No. 1458031-48-5
RUSKI-201( RUSKI 201 | RUSKI201 )
Catalog No. M11977 CAS No. 1458031-48-5
A potent, selective and cell active Hedgehog acyltransferase (Hhat) inhibitor with IC50 of 0.87 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRUSKI-201
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective and cell active Hedgehog acyltransferase (Hhat) inhibitor with IC50 of 0.87 uM.
-
DescriptionA potent, selective and cell active Hedgehog acyltransferase (Hhat) inhibitor with IC50 of 0.87 uM; blocks Hh signaling in H520, Panc-1, and MCF-7 coculture with Shh-Light2 cells (IC50=4.8 uM, 7.8 uM, and 8.5 uM, respectively); selectively inhibits Hh palmitoylation over a panel of >100 palmitoylated substrates in cells.
-
In Vitro——
-
In Vivo——
-
SynonymsRUSKI 201 | RUSKI201
-
PathwayGPCR/G Protein
-
TargetHedgehog (Hh)
-
RecptorHedgehog (Hh)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1458031-48-5
-
Formula Weight357.516
-
Molecular FormulaC20H27N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=CC=CC(C2C(C=CS3)=C3CCN2C(CNCC(C)CC)=O)=N1
-
Chemical Name1-[6,7-Dihydro-4-(6-methyl-2-pyridinyl)thieno[3,2-c]pyridin-5(4H)-yl]-2-[(2-methylbutyl)amino]ethanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rodgers UR, et al. ACS Chem Biol. 2016 Dec 16;11(12):3256-3262.
molnova catalog
related products
-
RU-SKI 43
A small molecule inhibitor of Hhat (Hedgehog acyltransferase) with IC50 of 0.85 uM.
-
SANT-1
SANT-1 directly binds to Smoothened (Smo) receptor with Kd of 1.2 nM and inhibits Smo agonist effects with IC50 of 20 nM.
-
Epiberberine
Epiberberine may be caused drug interactions based on CYP2D6 enzyme. Epiberberine has anti-adipogenic effect is mediated by downregulation of the Raf/MEK1/ERK1/2 and AMPKα/Akt pathways during 3T3-L1 adipocyte differentiation.
